Private Equity
Up-and-down tariff moves underscore the uncertainty and volatility facing private equity firms and their investors globally this year.
6 min read · 14 April 2025
Private equity is still favoring technology, media and telecommunications.
3 min read · 14 April 2025
Cost containment, accelerated time-to-market, recurring revenues and strong cash flows are driving PE interest in the CDMO market.
3 min read · 11 April 2025
SNP was founded in 1994 and based in Heidelberg, Germany.
3 min read · 11 April 2025
Insights from dealmakers who attended ACG’s DealMax 2025 conference in Las Vegas; an update on companies for sale coverage; thoughts from an industrials-focused investment banker on how the tariff rollercoaster is affecting dealmaking in that sector.
5 min read · 10 April 2025
Namirial specializes in software that enables enterprises to verify identities, authenticate signatures and certify transactions.
5 min read · 10 April 2025
Michael Blankenship, co-chair of Winston & Strawn’s capital markets practice and Houston managing partner, on take-private deals in private equity this year; the subsector of food-service and why it’s attractive to PE firms; Bain Capital's deal for HealthEdge, a Burlington, Massachusetts-based healthcare tech company.
4 min read · 09 April 2025
The company’s product portfolio spans categories such as skin health, foot health, and intimate health, as well as digestive health and vitamins, minerals and supplements.
1 min read · 09 April 2025
OQ Chemicals is a global producer and merchant of oxo chemicals.
4 min read · 09 April 2025
Lead Edge Capital explains how tariffs and the stock market turmoil are affecting dealmaking.
4 min read · 08 April 2025
